Cyclerion Therapeutics (CYCN) Short Interest Ratio & Short Volume $3.19 +0.24 (+8.14%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cyclerion Therapeutics Short Interest DataCyclerion Therapeutics (CYCN) has a short interest of 747,900 shares, representing 38.16% of the float (the number of shares available for trading by the public). This marks a 13,498.18% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 845,317 shares to cover all short positions.Current Short Interest747,900 sharesPrevious Short Interest5,500 sharesChange Vs. Previous Month+13,498.18%Dollar Volume Sold Short$1.65 millionShort Interest Ratio0.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares2,710,000 sharesFloat Size1,960,000 sharesShort Percent of Float38.16%Today's Trading Volume267,665 sharesAverage Trading Volume845,317 sharesToday's Volume Vs. Average32% Short Selling Cyclerion Therapeutics? Sign up to receive the latest short interest report for Cyclerion Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCYCN Short Interest Over TimeCYCN Days to Cover Over TimeCYCN Percentage of Float Shorted Over Time Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Cyclerion Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024747,900 shares $1.65 million +13,498.2%38.2%0.3 $2.20 11/15/20245,500 shares $14,190.00 -61.8%0.3%0 $2.58 10/31/202414,400 shares $41,616.00 +20.0%0.7%1.1 $2.89 10/15/202412,000 shares $29,160.00 +11.1%0.6%1.9 $2.43 9/30/202410,800 shares $27,864.00 -17.6%0.5%1.8 $2.58 9/15/202413,100 shares $37,990.00 No Change0.6%2.3 $2.90 Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202413,100 shares $38,383.00 -3.0%0.6%2 $2.93 8/15/202413,500 shares $37,260.00 -18.2%0.7%2.2 $2.76 7/31/202416,500 shares $60,060.00 -4.6%0.8%2.8 $3.64 7/15/202417,300 shares $50,516.00 +10.9%0.8%3.6 $2.92 6/30/202415,600 shares $35,880.00 +7.6%0.8%3.9 $2.30 6/15/202414,500 shares $39,376.20 -18.5%0.7%4.5 $2.72 5/31/202417,800 shares $47,526.00 -4.3%0.9%8.9 $2.67 5/15/202418,600 shares $55,428.00 -4.1%0.9%8.1 $2.98 4/30/202419,400 shares $56,454.00 -4.0%1.0%7.2 $2.91 4/15/202420,200 shares $69,488.00 -8.6%1.0%7 $3.44 3/31/202422,100 shares $70,720.00 -6.0%1.2%7.4 $3.20 3/15/202423,500 shares $76,375.00 -4.9%1.3%7.8 $3.25 2/29/202424,700 shares $74,100.00 -7.8%1.3%4.2 $3.00 2/15/202426,800 shares $76,648.00 +9.8%1.6%3.6 $2.86 1/31/202424,400 shares $73,200.00 -5.8%1.4%3.1 $3.00 1/15/202425,900 shares $94,535.00 -15.1%1.5%3.4 $3.65 12/31/202330,500 shares $102,175.00 +1.0%1.7%3.5 $3.35 12/15/202330,200 shares $82,748.00 +87.6%1.7%3.5 $2.74 11/30/202316,100 shares $34,776.00 +21.1%0.9%2.2 $2.16 11/15/202313,300 shares $25,403.00 -14.2%0.7%2.1 $1.91 10/31/202315,500 shares $40,300.00 -13.9%0.8%2.2 $2.60 10/15/202318,000 shares $61,380.00 +13.2%0.9%2.1 $3.41 9/30/202315,900 shares $54,378.00 -14.5%0.8%1.8 $3.42 9/15/202318,600 shares $69,750.00 +5.7%1.0%1.8 $3.75 8/31/202317,600 shares $63,184.00 -31.8%0.8%1.6 $3.59 8/15/202325,800 shares $94,428.00 +23.4%1.2%2.1 $3.66 7/31/202320,900 shares $64,790.00 -37.8%1.0%0.7 $3.10 7/15/202333,600 shares $137,760.00 +20.0%1.6%1.1 $4.10 6/30/202328,000 shares $115,080.00 -22.7%1.2%1 $4.11 6/15/202336,200 shares $167,244.00 No Change1.7%1 $4.62 5/31/202336,200 shares $157,480.86 +168.2%1.9%1 $4.35 5/15/202313,500 shares $51,624.00 No Change0.8%0.4 $3.82 10/31/2022445,800 shares $245,190.00 +202.2%N/A2.1 $0.55 10/15/2022147,500 shares $61,404.25 -23.0%N/A0.7 $0.42Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 9/30/2022191,600 shares $164,776.00 -28.2%N/A1.3 $0.86 9/15/2022267,000 shares $245,613.30 +29.4%N/A1.7 $0.92 8/31/2022206,300 shares $173,292.00 +23.1%N/A0.8 $0.84 8/15/2022167,600 shares $149,164.00 -17.6%N/A0.6 $0.89 7/31/2022203,500 shares $195,360.00 -16.7%N/A0.8 $0.96 7/15/2022244,400 shares $221,426.40 -7.7%N/A1 $0.91 6/30/2022264,700 shares $145,267.36 +4.7%N/A1.1 $0.55 6/15/2022252,800 shares $122,987.20 +12.2%N/A1 $0.49 5/31/2022225,400 shares $140,334.04 -11.5%N/A1.7 $0.62 5/15/2022254,800 shares $143,962.00 -10.8%N/A2.2 $0.57 4/30/2022285,500 shares $210,270.75 -17.4%N/A2.4 $0.74 4/15/2022345,500 shares $345,500.00 -5.8%N/A2.6 $1.00 3/31/2022366,800 shares $407,148.00 -6.9%N/A2.6 $1.11 3/15/2022393,800 shares $393,800.00 -20.1%N/A2.2 $1.00 2/28/2022492,900 shares $517,545.00 -7.9%N/A2.3 $1.05 2/15/2022535,400 shares $599,648.00 -15.6%N/A1.7 $1.12 1/31/2022634,300 shares $837,276.00 +0.7%N/A1.9 $1.32 1/15/2022629,800 shares $875,422.00 +0.8%N/A1.8 $1.39 12/31/2021624,800 shares $1.07 million -59.4%N/A1.6 $1.72 12/15/20211,540,000 shares $2.70 million -6.1%N/A3.9 $1.75 11/30/20211,640,000 shares $3.58 million +11.6%N/A3.7 $2.18 11/15/20211,470,000 shares $3.95 million +1.4%N/A3.6 $2.69 10/29/20211,450,000 shares $3.71 million +17.9%N/A4 $2.56 10/15/20211,230,000 shares $3.31 million +6.0%N/A3.1 $2.69 9/30/20211,160,000 shares $3.56 million -2.5%N/A2.4 $3.07 9/15/20211,190,000 shares $3.50 million -1.7%N/A2 $2.94 8/31/20211,210,000 shares $4.14 million -6.2%N/A1.7 $3.42 8/13/20211,290,000 shares $4.09 million -7.2%N/A1 $3.17 7/30/20211,390,000 shares $4.04 million -12.6%N/A1 $2.91 7/15/20211,590,000 shares $5.26 million -14.5%4.7%1.1 $3.31 6/30/20211,860,000 shares $7.25 million -41.5%5.5%1.4 $3.90 6/15/20213,180,000 shares $11.99 million +105.2%11.6%2.5 $3.77 5/28/20211,550,000 shares $5.02 million -11.4%5.6%1.4 $3.24 5/14/20211,750,000 shares $4.92 million +71.6%N/A3.2 $2.81 4/30/20211,020,000 shares $2.34 million +42.1%N/A1.9 $2.29 4/15/2021717,900 shares $1.97 million -6.7%N/A1 $2.75 3/31/2021769,300 shares $2.07 million +22.9%N/A1.1 $2.69 3/15/2021626,100 shares $2.67 million +14.7%N/A1 $4.27 2/26/2021546,000 shares $2.09 million -20.7%N/A0.8 $3.82 2/12/2021688,800 shares $3.09 million +12.6%N/A1 $4.49 1/29/2021611,700 shares $1.90 million +12.4%N/A0.9 $3.11 1/15/2021544,200 shares $1.86 million -6.7%N/A1.5 $3.42 12/31/2020583,000 shares $1.80 million -1.6%N/A1 $3.08 12/15/2020592,700 shares $1.94 million -3.6%N/A1 $3.27 11/30/2020614,700 shares $2.00 million -18.0%N/A1 $3.26 11/15/2020749,200 shares $2.12 million -4.1%N/A1.3 $2.83 10/30/2020781,000 shares $1.80 million -20.4%N/A1.5 $2.31 10/15/2020980,700 shares $3.29 million +4.6%N/A2 $3.35 9/30/2020937,900 shares $5.70 million +10.6%N/A3.4 $6.08 9/15/2020847,800 shares $6.35 million -7.1%N/A3 $7.49Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 8/31/2020913,000 shares $6.23 million -1.0%N/A3.1 $6.82 8/14/2020922,200 shares $4.79 million +9.9%N/A3.2 $5.19 7/31/2020839,500 shares $3.21 million -7.2%N/A3.1 $3.82 7/15/2020904,600 shares $4.27 million -13.0%3.9%3.7 $4.72 6/30/20201,040,000 shares $6.15 million +26.3%4.5%4.6 $5.91 6/15/2020823,400 shares $3.80 million -16.9%3.6%3.6 $4.61 5/29/2020990,200 shares $4.00 million -15.4%4.3%4.1 $4.04 5/15/20201,170,000 shares $4.25 million -6.4%5.1%4.1 $3.63 4/30/20201,250,000 shares $4.84 million -3.9%5.4%3.5 $3.87 4/15/20201,300,000 shares $4.25 million -13.3%5.5%3.2 $3.27 3/31/20201,500,000 shares $5.42 million -28.9%6.3%2.7 $3.61 3/13/20202,110,700 shares $5.80 million +8.8%9.0%6.3 $2.75 2/28/20201,940,000 shares $6.09 million +19.8%8.3%2.6 $3.14 2/14/20201,620,000 shares $5.28 million +1.3%6.9%2.1 $3.26 1/31/20201,600,000 shares $7.04 million +17.7%6.1%1.9 $4.40 1/15/20201,360,000 shares $5.63 million +75.3%5.2%1.4 $4.14 12/31/2019776,000 shares $2.82 million +6.3%3.0%0.9 $3.64 CYCN Short Interest - Frequently Asked Questions What is Cyclerion Therapeutics' current short interest? Short interest is the volume of Cyclerion Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 747,900 shares of CYCN short. 38.16% of Cyclerion Therapeutics' shares are currently sold short. Learn More on Cyclerion Therapeutics' current short interest. What is a good short interest percentage for Cyclerion Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 38.16% of Cyclerion Therapeutics' floating shares are currently sold short. Is Cyclerion Therapeutics' short interest increasing or decreasing? Cyclerion Therapeutics saw a increase in short interest in November. As of November 30th, there was short interest totaling 747,900 shares, an increase of 13,498.2% from the previous total of 5,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cyclerion Therapeutics' float size? Cyclerion Therapeutics currently has issued a total of 2,710,000 shares. Some of Cyclerion Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cyclerion Therapeutics currently has a public float of 1,960,000 shares. How does Cyclerion Therapeutics' short interest compare to its competitors? 38.16% of Cyclerion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cyclerion Therapeutics: Actinium Pharmaceuticals, Inc. (6.89%), VYNE Therapeutics Inc. (0.51%), OncoCyte Co. (1.57%), Elevation Oncology, Inc. (11.78%), CalciMedica, Inc. (0.80%), Lumos Pharma, Inc. (0.97%), Lantern Pharma Inc. (1.99%), Marker Therapeutics, Inc. (0.78%), Barinthus Biotherapeutics plc (0.04%), Tempest Therapeutics, Inc. (6.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Cyclerion Therapeutics stock? Short selling CYCN is an investing strategy that aims to generate trading profit from Cyclerion Therapeutics as its price is falling. CYCN shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cyclerion Therapeutics? A short squeeze for Cyclerion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYCN, which in turn drives the price of the stock up even further. How often is Cyclerion Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYCN, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Actinium Pharmaceuticals Short Squeeze VYNE Therapeutics Short Squeeze OncoCyte Short Squeeze Elevation Oncology Short Squeeze CalciMedica Short Squeeze Lumos Pharma Short Squeeze Lantern Pharma Short Squeeze Marker Therapeutics Short Squeeze Barinthus Biotherapeutics Short Squeeze Tempest Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CYCN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCN Stock Alerts